ANI Pharmaceuticals, Inc.
Health
Performance
6.5
Risk
Sell
Buy
Curious about the Scores? Learn more.

ANI Pharmaceuticals, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

28.01.2026
Back on its feet. Fundamentals looking less chaotic.
15.11.2025
Still winning, but momentum’s cooling a bit.
29.08.2025
Trouble brewing. Volatility and pressure rising.
20.08.2025
Pulse detected. Still fragile, but stabilizing.

ANI Pharmaceuticals, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does ANI Pharmaceuticals, Inc. do? Business model and key facts

Get the full picture of ANI Pharmaceuticals, Inc.: what it builds, where it operates, and how it makes money.

ANI Pharmaceuticals, Inc. Profile

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees (FY): 897

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.

shop
Company facts
Nikhil Lalwani
CEO
897
Employees worldwide
shop
Performance
33.15%
Last 12 months
160.95%
Last 5 years
shop
Growth
$614,38M
Revenue year
$-18.522.000
Net income
shop
Valuation
$1,81B
Market Cap
-57.66
Price/Earnings Ratio

Stocks related to ANI Pharmaceuticals, Inc.

Selected based on industry alignment and relative market positioning.

DVAX
Dynavax Technologies Corporation
15.48
-0.26%
7.0
Sell
Buy
Dynavax Technologies Corporation
PRGO
Perrigo Company plc
14.00
-2.78%
8.3
Sell
Buy
Perrigo Company plc
AVDL
Avadel Pharmaceuticals plc
21.56
-0.05%
7.4
Sell
Buy
Avadel Pharmaceuticals plc
ALVO
Alvotech
5.31
-0.38%
8.1
Sell
Buy
Alvotech
PAHC
Phibro Animal Health Corporation
39.52
+0.10%
4.7
Sell
Buy
Phibro Animal Health Corporation

ANI Pharmaceuticals, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.